{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-114690","form_type":"8-K","ticker":"HURA","cik":"0001498382","company_name":"TuHURA Biosciences, Inc./NV","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.597335+00:00","generated_at":"2026-05-30T14:31:50.861457+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Kintara retracts Oct 17 CVR record date; CVRs to pre-reverse-split holders ahead of Oct 18 merger","bullets":["CVRs will be issued to stockholders of record immediately prior to the 1-for-35 reverse split, not on Oct 17 as previously announced.","Reverse split and merger with TuHURA expected to close Oct 18, subject to regulatory approval and remaining conditions.","Each CVR entitles holder to aggregate of up to 53,897,125 shares of common stock upon milestone achievement, adjusted for reverse split.","Kintara does not anticipate the correction will change which stockholders receive CVRs or the number received.","Previously approved reverse split range was 1-for-20 to 1-for-40; final ratio set at 1-for-35."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-114690","json":"https://secwatch.observer/filing/0000950170-24-114690.json","markdown":"https://secwatch.observer/filing/0000950170-24-114690.md","text":"https://secwatch.observer/filing/0000950170-24-114690.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1498382/000095017024114690/0000950170-24-114690-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1498382/000095017024114690/ktra-20241014.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:31:50.861457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}